Business
Avivagen Inc. Commences Trading on the OTCQB® Venture Market in the U.S.
Avivagen Inc. Commences Trading on the OTCQB® Venture Market in the U.S..
About this update from Avivagen, Inc.
[{"type":"text","content":"\nAvivagen Inc. (TSXV:VIV, OTCQB: VIVXF) (“Avivagen”), a life sciences innovation company with a series of patent protected products that support and optimize human and animal health, is pleased to announce that it has qualified to trade its common shares in the United States on the OTCQB® Venture Market (“OTCQB®”). Avivagen will begin trading on the OTCQB® Venture Market today under the symbol “VIVXF”.\n\n\n“We are delighted that our shares launch on the OTCQB®, and we believe that trading on the OTCQB® will provide additional liquidity and help us expand Avivagen’s investor presence in the United States,” said Kym Anthony, Chief Executive Officer, Avivagen Inc. “This represents another positive step in Avivagen’s ongoing evolution as we bring OxC-betaTM, OxC-betaTM Livestock and its companion animal products to new customers and markets around the world.”\n\n\nThe increased scrutiny required to list on the OTCQB® provides investors with greater financial transparency when making investment decisions. U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for Avivagen on www.otcmarkets.com.\n\n\nAbout the OTCQB Venture Market\nThe OTCQB® Venture Market is for entrepreneurial and development stage U.S. and international companies.\n\n\nAbout Avivagen\nAvivagen is a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance. It is a public corporation traded on the TSX Venture Exchange under the symbol VIV and is headquartered in Ottawa, Canada, based in partnership facilities of the National Research Council of Canada and Charlottetown, Prince Edward Island. For more information, visit www.avivagen.com. The contents of the website are expressly not incorporated by reference in this press release.\n\n\nAbout OxC-beta™ Technology and OxC-beta™ Livestock\nAvivagen’s OxC-beta™ technology is derived from Avivagen discoveries about carotenoids, compounds that give certain fruits and vegetables their bright colours, and is a non-antibiotic means of maintaining optimal health and growth. OxC-beta™ Livestock is a proprietar...